Govindappa, Nagaraj,Soares, Maria Melina,Sastry, Kedarnath
申请号：
NZ71144514
公开号：
NZ711445A
申请日:
2014.03.10
申请国别(地区):
NZ
年份:
2018
代理人:
摘要：
The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti- EGFRl-TGFβRII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.
